Summary
SIS Testanon 400, a multi-testosterone ester injectable manufactured by SIS Labs, underwent independent testing by SIMEC AG, an ISO-accredited laboratory, to verify its composition, dosing accuracy, and microbiological safety. The sample, identified by batch 001-30660 with an expiration date of February 2021, was submitted and funded by AnabolicLab.com.
The analysis confirmed the presence of most declared compounds, though Testosterone Acetate failed to meet its specification, as it was not detected. The measured concentrations of the other testosterone esters showed variances from the labeled claims, some significantly. Microbiological testing revealed no contamination.
Detailed Report
Product Overview
- Manufacturer: SIS Labs
- Product Name: Testanon 400
- Batch Number: 001-30660
- Manufacture Date: February 2017
- Expiration Date: February 2021
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: C 67066
- Testing Ordered: 28 February 2018
- Sample Received: 28 February 2018
- Analysis Conducted By: SIMEC AG
- Product Submitted By: AnabolicLab.com
- Analysis Paid For By: AnabolicLab.com
Testing Results
| Compound | Specification (Label Claim) | Measured Concentration | Accuracy | Variance | Compliance |
|---|---|---|---|---|---|
| Testosterone Acetate | 20 mg/ml | Not detected | 0.00% | -100% | No |
| Testosterone Propionate | 30 mg/ml | 47.2 mg/ml | 157.33% | +57.33% | Yes |
| Testosterone Phenylpropionate | 30 mg/ml | 46.2 mg/ml | 154.00% | +54.00% | Yes |
| Testosterone Cypionate | 120 mg/ml | 48.8 mg/ml | 40.67% | -59.33% | No |
| Testosterone Decanoate | 200 mg/ml | 90.3 mg/ml | 45.15% | -54.85% | No |
| Microbiological Testing | Result | Specification |
|---|---|---|
| TAMC | <1 KBE/ml | Complies |
| TYMC | <1 KBE/ml | Complies |
Evaluation of Independent Testing
The analysis reveals significant inconsistencies in the formulation of SIS Testanon 400. While Testosterone Propionate and Phenylpropionate exceeded label claims, Testosterone Acetate was not detected, and both Testosterone Cypionate and Decanoate fell far below the stated concentrations. These findings suggest poor manufacturing consistency for this batch. Although microbiological testing confirms the absence of contamination, the significant variances in the active ingredient concentrations raise concerns about quality control.
This report applies exclusively to the tested batch, and further independent testing is recommended to assess the consistency of other batches in the market.
Conclusion
The independent analysis of SIS Testanon 400 highlights significant formulation discrepancies, including the complete absence of Testosterone Acetate and underdosing of other esters. While some compounds exceeded label claims, others were significantly below specifications. This lack of consistency emphasizes the need for more stringent manufacturing controls and third-party testing to ensure product reliability.
Disclaimer
This report is published for educational and harm reduction purposes. It pertains solely to the tested batch and does not generalize to all products under the same name. Manufacturer-funded testing may carry inherent biases, and readers are encouraged to cross-reference these findings with independent third-party analyses for a comprehensive evaluation.
Discuss the SIS Laboratories Testanon 400 lab test results on the AnabolicLab Forum.
(The following images are photographs of the actual product that was submitted for testing.)
